Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Therapeutic response changed? 53 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Therapeutic response changed have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

53
Reports of Therapeutic response changed with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
1
Deaths
7
Hospitalizations

How Dangerous Is Therapeutic response changed From ADALIMUMAB?

Of the 53 reports, 1 (1.9%) resulted in death, 7 (13.2%) required hospitalization.

Is Therapeutic response changed Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 53 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Therapeutic response changed?

TIRZEPATIDE (550) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (169) LEVOTHYROXINE (124) METHYLPHENIDATE (124) LAMOTRIGINE (111) LISDEXAMFETAMINE DIMESYLATE (104) BUPROPION (99) NAPROXEN (63) PREGABALIN (59) CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (55)

Which ADALIMUMAB Alternatives Have Lower Therapeutic response changed Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Therapeutic response changed Reports All Drugs Causing Therapeutic response changed ADALIMUMAB Demographics